ReviewBiologics : targets & therapy2016

Therapeutic efficacy of monthly subcutaneous injection of daclizumab in relapsing multiple sclerosis.

Stanley CohanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.